These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 30066936)

  • 21. High Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells.
    Fujita H; Gomori A; Fujioka Y; Kataoka Y; Tanaka K; Hashimoto A; Suzuki T; Ito K; Haruma T; Yamamoto-Yokoi H; Harada N; Sakuragi M; Oda N; Matsuo K; Inada M; Yonekura K
    PLoS One; 2016; 11(10):e0164830. PubMed ID: 27736957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems.
    Liverani C; Mercatali L; Spadazzi C; La Manna F; De Vita A; Riva N; Calpona S; Ricci M; Bongiovanni A; Gunelli E; Zanoni M; Fabbri F; Zoli W; Amadori D; Ibrahim T
    Bone; 2014 Sep; 66():214-22. PubMed ID: 24956020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The PI3K inhibitor buparlisib suppresses osteoclast formation and tumour cell growth in bone metastasis of lung cancer, as evidenced by multimodality molecular imaging.
    Wang S; Niu X; Bao X; Wang Q; Zhang J; Lu S; Wang Y; Xu L; Wang M; Zhang J
    Oncol Rep; 2019 May; 41(5):2636-2646. PubMed ID: 30896825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
    Kitazawa S; Kitazawa R
    J Pathol; 2002 Oct; 198(2):228-36. PubMed ID: 12237883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.
    Pivetta E; Scapolan M; Pecolo M; Wassermann B; Abu-Rumeileh I; Balestreri L; Borsatti E; Tripodo C; Colombatti A; Spessotto P
    Breast Cancer Res; 2011 Oct; 13(5):R105. PubMed ID: 22032644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis.
    Yamaguchi M; Zhu S; Zhang S; Wu D; Moore TM; Snyder JP; Shoji M
    Cell Tissue Res; 2014 Jul; 357(1):245-52. PubMed ID: 24723227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption.
    Strube A; Hoffmann J; Stepina E; Hauff P; Klar U; Käkönen SM
    Clin Cancer Res; 2009 Jun; 15(11):3751-9. PubMed ID: 19470728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platycodin D Blocks Breast Cancer-Induced Bone Destruction by Inhibiting Osteoclastogenesis and the Growth of Breast Cancer Cells.
    Lee SK; Park KK; Kim HJ; Kim KR; Kang EJ; Kim YL; Yoon H; Kim YS; Chung WY
    Cell Physiol Biochem; 2015; 36(5):1809-20. PubMed ID: 26184636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
    Mancino AT; Klimberg VS; Yamamoto M; Manolagas SC; Abe E
    J Surg Res; 2001 Sep; 100(1):18-24. PubMed ID: 11516200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms.
    Lee JH; Kim B; Jin WJ; Kim JW; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2014 Sep; 91(1):51-60. PubMed ID: 24929117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells.
    Nakata A; Tsujimura T; Sugihara A; Okamura H; Iwasaki T; Shinkai K; Iwata N; Kakishita E; Akedo H; Terada N
    Anticancer Res; 1999; 19(5B):4131-8. PubMed ID: 10628364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of antitumor treatment conditions for transcutaneous CO2 application: An in vivo study.
    Ueha T; Kawamoto T; Onishi Y; Harada R; Minoda M; Toda M; Hara H; Fukase N; Kurosaka M; Kuroda R; Akisue T; Sakai Y
    Oncol Rep; 2017 Jun; 37(6):3688-3694. PubMed ID: 28440513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
    Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
    J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis.
    Siclari VA; Mohammad KS; Tompkins DR; Davis H; McKenna CR; Peng X; Wessner LL; Niewolna M; Guise TA; Suvannasankha A; Chirgwin JM
    Breast Cancer Res; 2014 Dec; 16(6):458. PubMed ID: 25439669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer.
    Urakawa H; Nishida Y; Knudson W; Knudson CB; Arai E; Kozawa E; Futamura N; Wasa J; Ishiguro N
    J Orthop Res; 2012 Apr; 30(4):662-72. PubMed ID: 21913222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice.
    Yan W; Wang TY; Fan QM; Du L; Xu JK; Zhai ZJ; Li HW; Tang TT
    Acta Pharmacol Sin; 2014 Jan; 35(1):124-34. PubMed ID: 24384612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.
    Saito H; Tsunenari T; Onuma E; Sato K; Ogata E; Yamada-Okabe H
    Anticancer Res; 2005; 25(6B):3817-23. PubMed ID: 16309168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models.
    Liapis V; Zinonos I; Labrinidis A; Hay S; Ponomarev V; Panagopoulos V; Zysk A; DeNichilo M; Ingman W; Atkins GJ; Findlay DM; Zannettino AC; Evdokiou A
    Cancer Med; 2016 Mar; 5(3):534-45. PubMed ID: 26749324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis.
    Ooi LL; Zheng Y; Zhou H; Trivedi T; Conigrave AD; Seibel MJ; Dunstan CR
    Bone; 2010 Oct; 47(4):795-803. PubMed ID: 20638491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proline/arginine-rich end leucine-rich repeat protein N-terminus is a novel osteoclast antagonist that counteracts bone loss.
    Rucci N; Capulli M; Ventura L; Angelucci A; Peruzzi B; Tillgren V; Muraca M; Heinegård D; Teti A
    J Bone Miner Res; 2013 Sep; 28(9):1912-24. PubMed ID: 23559035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.